We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+4.91%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.68B
AUM Growth
-$145M
Cap. Flow
-$113M
Cap. Flow %
-2.41%
Top 10 Hldgs %
14.09%
Holding
1,671
New
224
Increased
657
Reduced
447
Closed
328

Top Buys

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$29M
2
NU icon
Nu Holdings
NU
+$25.8M
3
PG icon
Procter & Gamble
PG
+$23.5M
4
NKE icon
Nike
NKE
+$23.1M
5
GRAB icon
Grab
GRAB
+$22.3M

Top Sells

Rank Stock Value
1
JD icon
JD.com
JD
+$44.7M
2
NTES icon
NetEase
NTES
+$40.5M
3
AMD icon
Advanced Micro Devices
AMD
+$37.8M
4
MELI icon
Mercado Libre
MELI
+$33.9M
5
PDD icon
Pinduoduo
PDD
+$33.8M

Sector Composition

Rank Sector Weight
1 Technology 30.82%
2 Consumer Discretionary 19.78%
3 Communication Services 10.14%
4 Financials 6.66%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CCXI
1626
DELISTED
ChemoCentryx, Inc.
CCXI
– –
-1,600
Closed -$27K
FMTX
1627
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
– –
-1,085
Closed -$25K
GBT
1628
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-1,430
Closed -$36K
BRG
1629
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
– –
-7,802
Closed -$99K
CTXS
1630
DELISTED
Citrix Systems Inc
CTXS
– –
-442
Closed -$47K
ENDP
1631
DELISTED
Endo International plc
ENDP
– –
-5,345
Closed -$17K
TPTX
1632
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
– –
-1,125
Closed -$74K
RDUS
1633
DELISTED
Radius Health, Inc.
RDUS
– –
-1,080
Closed -$13K
EPZM
1634
DELISTED
Epizyme, Inc
EPZM
– –
-2,340
Closed -$11K
CALA
1635
DELISTED
Calithera Biosciences, Inc
CALA
– –
-85
Closed -$3K
MIME
1636
DELISTED
Mimecast Limited
MIME
– –
-10,566
Closed -$671K
KLDO
1637
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
– –
-970
Closed -$5K
CSPR
1638
DELISTED
Casper Sleep Inc.
CSPR
– –
-1,823,522
Closed -$7.79M
ODT
1639
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
– –
-880
Closed -$2K
DCRN
1640
DELISTED
Decarbonization Plus Acquisition Corporation II Class A Common stock
DCRN
– –
-6,598
Closed -$65K
DRNA
1641
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-1,780
Closed -$35K
COR
1642
DELISTED
Coresite Realty Corporation
COR
– –
-47,982
Closed -$6.65M
HCAQ
1643
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
– –
-3,967
Closed -$39K
IIAC
1644
DELISTED
Investindustrial Acquisition Corp.
IIAC
– –
-5,050
Closed -$50K
BSN
1645
DELISTED
Broadstone Acquisition Corp.
BSN
– –
-5,086
Closed -$50K
YAC
1646
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
– –
-7,167
Closed -$70K
KSU
1647
DELISTED
Kansas City Southern
KSU
– –
-327
Closed -$88K
PCI
1648
DELISTED
PIMCO Dynamic Credit and Mortgage Income Fund
PCI
– –
-639,654
Closed -$13.5M
SVOK
1649
DELISTED
Seven Oaks Acquisition Corp. Class A Common Stock
SVOK
– –
-7,178
Closed -$71K
DGNS
1650
DELISTED
Dragoneer Growth Opportunities Corp. II Class A Ordinary Shares
DGNS
– –
-4,517
Closed -$44K
63 64 65
66
67

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Penserra Capital Management held 1,671 positions worth $4.68B, down 3% from $4.82B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Penserra Capital Management's Q4 2021 filing shows 224 new, 657 increased, 447 reduced and 328 closed positions. Its largest new stake was Marathon Petroleum: 451,379 shares worth $28.9M. The largest sale was JD.com, an estimated $44.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q4 2021 buy was Marathon Petroleum: 451,379 shares worth $28.9M.
  • Penserra Capital Management added most to Procter & Gamble in Q4 2021, an estimated $23.5M increase.
  • Penserra Capital Management's biggest Q4 2021 reduction was JD.com, cutting an estimated $44.7M.
  • Penserra Capital Management fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $32.7M.
  • Penserra Capital Management's ten largest holdings make up 14% of its $4.68B portfolio in Q4 2021.
  • Penserra Capital Management opened 224 new positions and closed 328 in Q4 2021.
  • Penserra Capital Management's portfolio value fell 3% quarter-over-quarter to $4.68B.

Based on Penserra Capital Management's 13F filing for Q4 2021, filed 15 Feb 2022.